Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
株式のランク #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
株価
$0.0003
最終同期: 2026-08-11
時価総額
$21.97K
変化(1日)
0.00%
変化(1年)
200.00%
US
取引 MabCure Inc. (MBCI)

カテゴリー

MabCure Inc.(MBCI)のP/S比率
2026 時点のP/S比率 TTM: 0
MabCure Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
MabCure Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。